Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Ovarian Hyperstimulation Syndrome

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Ovarian Hyperstimulation Syndrome:

Pubmed Logo
Preventive ethics and subsequent care of patients self-administering ovarian stimulation for the management of infertility.
Abstract Objective. Ovarian hyperstimulation syndrome (OHSS) is a severe...
18th November, 2009
Department of Obstetrics and Gynecology, Weill Medical College of Cornell J Clin Ethics. 2009 Fall;20(3):239-40.
Non-adherence to instructions to cancel a cycle in a patient overstimulated with gonadotropins in a planned intrauterine insemination cycle.
Abstract Objective. Ovarian hyperstimulation syndrome (OHSS) is a severe...
18th November, 2009
Division of Reproductive Endocrinology and Infertility, Department of J Clin Ethics. 2009 Fall;20(3):235-8.
[Ovarian hyperstimulation syndrome in a 19-years-old woman.]
Premature ovarian failure as a consequence of childhood cancer treatment...
17th November, 2009
Servicio de Medicina Intensiva, Hospital Universitari Germans Trias i Med Clin (Barc). 2009 Nov 12.
DOI Direct Link
GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study.
The use of gonadotrophin-releasing hormone (GnRH) agonists for triggering...
17th November, 2009
Instituto Valenciano de Infertilidad, Universidad de Valencia, Valencia Reprod Biomed Online. 2009 Oct;19(4):486-92.
Failure of cabergoline to prevent severe ovarian hyperstimulation syndrome in patients with extremely high estradiol levels.
The use of gonadotrophin-releasing hormone (GnRH) agonists for triggering...
10th November, 2009
Department of Obstetrics and Gynecology, Shin Kong Wu Ho-Su Memorial Int J Gynaecol Obstet. 2009 Nov 6.
DOI Direct Link

View more research publications.

Press Releases About Ovarian Hyperstimulation Syndrome:

BioPortfolio Logo
AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 24th November, 2009 AETERNA ZENTARIS INC.
Primary efficacy endpoint has been met for patients with advanced-stage or recurrent endometrial cancer QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS;
Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 23rd November, 2009 Lexicon Pharmaceuticals, Inc.
THE WOODLANDS, Texas, Nov. 23 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that top-line data from its Phase 2 clinical study with LX1031 in patients with
Merck Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA(R) 20th November, 2009 Merck & Co., Inc.
WHITEHOUSE STATION, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Merck & Co., Inc. today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has
Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 18th November, 2009 Viron Therapeutics Inc.
VT-111 significantly reduces key cardiac enzymes at multiple time points after stent placement; Data presented at American Heart Association 2009 Scientific Sessions LONDON, ON, Nov. 18 /PRNewswire/
Oklahoma Medical Research Foundation Accelerates Discovery With Isilon IQ 18th November, 2009 Isilon Systems
SEATTLE, Nov. 18 /PRNewswire-FirstCall/ -- IsilonĀ® Systems (Nasdaq: ISLN) today announced that the Oklahoma Medical Research Foundation (OMRF), a nonprofit biomedical research institute, has

BioNews Results for Ovarian Hyperstimulation Syndrome:

RSS Logo
BioPortfolio Logo
EU Panel: Affirm Benefits Of Celvapan, Focetria, Pandemrix
Lloyd's:  Nov 20 2009 3:08PM Matching: ovarian syndrome
EU Panel: Affirm Benefits Of Celvapan, Focetria, Pandemrix
Morningstar.com:  Nov 20 2009 1:55PM Matching: ovarian syndrome
EU Panel: Affirm Benefits Of Celvapan, Focetria, Pandemrix
CNN Money:  Nov 20 2009 1:41PM Matching: ovarian syndrome
EU Panel: Affirm Benefits Of Celvapan, Focet
Hemscott:  Nov 20 2009 1:41PM Matching: ovarian syndrome
EU Panel Backs Elonva from N.V. Organon
Hemscott:  Nov 20 2009 1:23PM Matching: ovarian syndrome
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Ovarian Hyperstimulation Syndrome Patents:

USPTO Logo
US Patent No.Title
7070959 Modified chimeric polypeptides with improved pharmacokinetic properties
7267651 Method and apparatus for blood flow measurement using millimeter wave band
7291593 Use of fish for treating infertility
7303746 Methods of treating eye disorders with modified chimeric polypeptides
7307088 Substituted anthranilic amide derivatives and methods of use

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Ovarian Hyperstimulation Syndrome scientists - we have details of around 166 individuals working on Ovarian Hyperstimulation Syndrome .


This page has been viewed 359 times
Recent Search Terms used to find this page: ovarian caval syndrome | ovarian hyperstimulation syndrome 2009 | ohss,free,download | 7241577 license | symposium update on prediction and management of OHSS 2009 | success ivf post hyper stimulation | Symposium Update on prediction and management of OHSS prevention of OHSS. | cabergoline ovarian hyperstimulation syndrome | cabergoline ovarian hyperstimulation syndrome | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Ovarian Hyperstimulation Syndrome across BioPortfolio, or for Ovarian Hyperstimulation Syndrome Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.